Shopping Cart 0
Cart Subtotal
USD 0

PerkinElmer Inc (PKI) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services to diagnostics, research, food, laboratory services, environmental, and industrial markets. The company's major products include cytogenetics reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography instruments, molecular spectroscopy, newborn screening instruments and thermal analysis instruments, among others. It offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. PerkinElmer also offers cord blood and tissue banking, laboratory and research services, among others. Its products are used in various applications, including atomic spectroscopy, cell imaging and analysis, chromatography, DNA/RNA isolation, analysis and detection, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others. The company operates in Asia-Pacific, Europe and North America, among others. PerkinElmer is headquartered in Waltham, Massachusetts, US.

PerkinElmer Inc (PKI)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

PerkinElmer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

PerkinElmer Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8

PerkinElmer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

PerkinElmer Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 10

PerkinElmer Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

PerkinElmer Inc, Medical Equipment, Deal Details 13

Partnerships 13

Euroimmun Enters into Licensing Agreement with Iron Horse Diagnostics 13

Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 14

PerkinElmer Expands Licensing Agreement With Tibco Software 15

PerkinElmer Enters Into Licensing Agreement With Tibco Software For Tibco Spotfire 16

PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 17

Agena Bioscience Enters into Agreement with PerkinElmer 18

Enzyvant Enters into Collaboration Agreement PerkinElmer 19

PerkinElmer Enters into Agreement with Helix OpCo 20

Mobidiag Expand Agreement with Wallac 21

10X Genomics Enters into Agreement with PerkinElmer 22

Euroimmun Enters into Agreement with Angsana Molecular & Diagnostics 23

Reproductive Health Science Enters into Distribution Agreement with Tani Medikal for EmbryoCellect 24

OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 25

Sofie Biosciences and PerkinElmer Extends Partnership 26

PerkinElmer Enters into Distribution Agreement with Sebia 27

Good Start Genetics Enters Into Agreement With PerkinElmer To Provide GoodStart Select Carrier Screening Tests 28

Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 29

ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 30

PerkinElmer Enters Into Agreement With National Center for Drug Screening 31

PerkinElmer Enters Into Co-Marketing Agreement With Verinata Health For Verifi Test 32

Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 33

Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 34

Equity Offering 35

Reproductive Health Science Raises USD1.12 Million in Private Placement of Shares 35

PerkinElmer Plans to Spin Out Diagnostics Business 36

Reproductive Health Science Raises USD1 Million in Private Placement of Shares 37

Debt Offering 38

PerkinElmer Raises USD370.1 Million in Public Offering of 0.6% Notes Due 2021 38

PerkinElmer Raises EUR553 Million in Public Offering of 1.875% Notes Due 2026 39

PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026 40

Asset Transactions 42

Varex Imaging Acquires Medical Imaging Business of PerkinElmer 42

Acquisition 43

PerkinElmer Acquires Euroimmun for USD1.34 Billion 43

PerkinElmer Acquires Tulip Diagnostics 45

PerkinElmer Acquires Bioo Scientific for USD63.5 Million 46

PerkinElmer Acquires Vanadis Diagnostics 47

AO Energy Completes Acquisition of Reproductive Health Science 48

PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech 49

PerkinElmer Inc-Key Competitors 50

PerkinElmer Inc-Key Employees 51

PerkinElmer Inc-Locations And Subsidiaries 52

Head Office 52

Other Locations & Subsidiaries 52

Joint Venture 57

Recent Developments 58

Strategy And Business Planning 58

Sep 21, 2017: State Key Laboratory of Biochemical Engineering and PerkinElmer Open Joint Translational Medical Engineering Demonstration Laboratory in Beijing 58

Financial Announcements 59

Aug 01, 2018: PerkinElmer Announces Financial Results for the Second Quarter of 2018 59

Apr 30, 2018: PerkinElmer Reports Financial Results for the First Quarter of 2018 60

Jan 25, 2018: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017 61

Nov 02, 2017: PerkinElmer Announces Financial Results for the Third Quarter of 2017 63

Aug 03, 2017: PerkinElmer Announces Financial Results for the Second Quarter of 2017 64

May 04, 2017: PerkinElmer Announces Financial Results for the First Quarter of 2017 65

Feb 02, 2017: PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2016 66

Corporate Communications 68

Apr 10, 2018: PerkinElmer Names James Mock as Chief Financial Officer 68

Oct 30, 2017: PerkinElmer Elects Pascale Witz to its Board of Directors 69

Sep 15, 2017: PerkinElmer Announces Future Retirement of Andy Wilson, Chief Financial Officer 70

Product News 71

Oct 02, 2018: PerkinElmer launches asset Genius System for remote laboratory monitoring 71

Jul 17, 2018: PerkinElmer to Highlight Comprehensive Diagnostics Technologies at AACC 2018 72

May 31, 2018: PerkinElmer Launches NEXTflex Unique Dual Index Barcodes for Increased Confidence in Sequencing Data 74

May 31, 2018: PerkinElmer to Highlight Mass Spectrometry and Chromatography Solutions at 2018 ASMS Conference 75

May 15, 2018: PerkinElmer Signals Screening Software Streamlines Data Analysis, Increases Speed and Reliability of Drug Discovery 76

May 10, 2018: PerkinElmer to Showcase Informatics Technologies at 2018 Bio-IT World Conference Expo 77

Apr 06, 2018: PerkinElmer to Display Broad Range of Advanced Laboratory Technologies at Analytica 2018 79

Jan 29, 2018: PerkinElmer Launches CE-IVD Assay Kit to Screen Newborns Affected by Duchenne Muscular Dystrophy 82

Jan 22, 2018: PerkinElmer to Showcase Innovative Workflow Solutions at SLAS 2018 83

Apr 03, 2017: New Cloud-Based PerkinElmer Signals Notebook Helps Scientists Accelerate Drug Discovery Research 85

Mar 23, 2017: PerkinElmer to Display Portfolio of Cancer Research Technologies and Workflow Solutions at 2017 AACR Annual Meeting 86

Jan 26, 2017: PerkinElmer Launches Vectra Polaris Automated Quantitative Pathology Imaging System 88

Other Significant Developments 89

Apr 05, 2018: Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program 89

Feb 28, 2018: PerkinElmer Signals Translational Contributes to Pre-Clinical and Clinical Data Analysis at the Frederick National Laboratory for Cancer Research 90

Sep 14, 2017: PerkinElmer and in-Depth Genomics Team Up for Whole Genome Sequencing Diagnostic Program for Rare Diseases 91

Aug 03, 2017: PerkinElmer Launches Clinical Whole Genome Sequencing Services 92

Mar 08, 2017: HISTALIM is The First European Laboratory to Adopt the Vectra Polaris Automated Quantitative Pathology Imaging System Developed by PerkinElmer 93

Appendix 94

Methodology 94

About GlobalData 94

Contact Us 94

Disclaimer 94


List Of Figure

List of Figures

PerkinElmer Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

PerkinElmer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

PerkinElmer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

PerkinElmer Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

PerkinElmer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

PerkinElmer Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 8

PerkinElmer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

PerkinElmer Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 10


List Of Table

List of Tables

PerkinElmer Inc, Medical Equipment, Key Facts, 2017 2

PerkinElmer Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

PerkinElmer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

PerkinElmer Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8

PerkinElmer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

PerkinElmer Inc, Deals By Market, 2012 to YTD 2018 10

PerkinElmer Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Euroimmun Enters into Licensing Agreement with Iron Horse Diagnostics 13

Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 14

PerkinElmer Expands Licensing Agreement With Tibco Software 15

PerkinElmer Enters Into Licensing Agreement With Tibco Software For Tibco Spotfire 16

PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 17

Agena Bioscience Enters into Agreement with PerkinElmer 18

Enzyvant Enters into Collaboration Agreement PerkinElmer 19

PerkinElmer Enters into Agreement with Helix OpCo 20

Mobidiag Expand Agreement with Wallac 21

10X Genomics Enters into Agreement with PerkinElmer 22

Euroimmun Enters into Agreement with Angsana Molecular & Diagnostics 23

Reproductive Health Science Enters into Distribution Agreement with Tani Medikal for EmbryoCellect 24

OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 25

Sofie Biosciences and PerkinElmer Extends Partnership 26

PerkinElmer Enters into Distribution Agreement with Sebia 27

Good Start Genetics Enters Into Agreement With PerkinElmer To Provide GoodStart Select Carrier Screening Tests 28

Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 29

ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 30

PerkinElmer Enters Into Agreement With National Center for Drug Screening 31

PerkinElmer Enters Into Co-Marketing Agreement With Verinata Health For Verifi Test 32

Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 33

Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 34

Reproductive Health Science Raises USD1.12 Million in Private Placement of Shares 35

PerkinElmer Plans to Spin Out Diagnostics Business 36

Reproductive Health Science Raises USD1 Million in Private Placement of Shares 37

PerkinElmer Raises USD370.1 Million in Public Offering of 0.6% Notes Due 2021 38

PerkinElmer Raises EUR553 Million in Public Offering of 1.875% Notes Due 2026 39

PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026 40

Varex Imaging Acquires Medical Imaging Business of PerkinElmer 42

PerkinElmer Acquires Euroimmun for USD1.34 Billion 43

PerkinElmer Acquires Tulip Diagnostics 45

PerkinElmer Acquires Bioo Scientific for USD63.5 Million 46

PerkinElmer Acquires Vanadis Diagnostics 47

AO Energy Completes Acquisition of Reproductive Health Science 48

PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech 49

PerkinElmer Inc, Key Competitors 50

PerkinElmer Inc, Key Employees 51

PerkinElmer Inc, Other Locations 52

PerkinElmer Inc, Subsidiaries 53

PerkinElmer Inc, Joint Venture 57

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

PerkinElmer Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.